Pharmacokinetics, toxicity and clinical efficacy of linezolid in Japanese pediatric patients

Keyphrases

• Absorption Model 9%
• All Pediatric 9%
• Appropriate Treatment 9%
• Body Function 9%
• Body Size 9%
• Body Temperature 18%
• C-reactive Protein 18%
• Clinical Efficacy 100%
• Cmin 18%
• Dose Adjustment 18%
• Efficacy Assessment 9%
• Elimination Half-life 9%
• End of Treatment 9%
• First-order 9%
• Individualized Dosing 9%
• Japanese Pediatric Patients 100%
• Linezolid 100%
• Minimum Concentration 9%
• One-compartment 9%
• Pediatric Patients 54%
• Pharmacokinetics 100%
• Protein Body 9%
• Protein Concentration 18%
• Routine Clinical Data 9%
• Safe Treatment 9%
• Serum Concentration 9%
• Thrombocytopenia 45%
• Total Concentration 9%
• Unbound Concentration 9%

Biochemistry, Genetics and Molecular Biology

• Absorption 9%
• Blood Level 9%
• Body Size 9%
• Body Temperature 18%
• Body Weight 9%
• C-Reactive Protein 18%
• Efficacy Assessment 9%
• Elimination Half-Life 9%
• Linezolid 100%
• Maturation 9%
• Minimum Concentration 27%
• Pharmacokinetics 100%
• Thrombocytopenia 45%

Pharmacology, Toxicology and Pharmaceutical Science

• C Reactive Protein 18%
• Cmin 18%
• Efficacy Assessment 9%
• Elimination 9%
• Linezolid 100%
• Pharmacokinetics 100%
• Thrombocytopenia 45%